Alder BioPharmaceuticals Forecast and Stock Analysis
Technical ALDR stock analysis for March 22, 2019.
Alder BioPharmaceuticals fell by -9.50% in the last day from $14.31 to $12.95 The price has risen in 6 of the last 10 days and is up by 6.67% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1 143 537 shares and in total 871 759 shares bought and sold for approximately $11.29 million.
Close price at the end of the last trading day (Friday, 22nd Mar 2019) of the ALDR stock was $12.95. This is 9.5% less than the trading day before Thursday, 21st Mar 2019.
During day the stock fluctuated 10.41% from a day low at $12.87 to a day high of $14.21.
30 day high of the ALDR stock price was $14.95 and low was $11.82.
90 day high was $15.17 and low was $9.44.
52 week high for the Alder BioPharmaceuticals - $20.87 and low - $9.44.
Alder BioPharmaceuticals lies in the lower part of a very wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $12.65 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 24.08% during the next 3 months and, with 90% probability hold a price between $15.70 and $19.75 at the end of this period.
There are few to none technical positive signals at the moment. Alder BioPharmaceuticals holds sales signals from both short- and long-term moving averages. On corrections up there will be some resistance from the lines at $13.61 and $13.52. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday March 21, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSI14 is 50 and the stock is currently not being overbought or oversold
Support & Resistance
Alder BioPharmaceuticals finds support from accumulated volume at $12.82.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.34 between high and low, or 10.41%. For the last week, the stock has had a daily average volatility of 6.50%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Evaluation: Strong Sell Candidate
The Alder BioPharmaceuticals stock holds several negative signals and despite the positive trend we believe Alder BioPharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Strong Sell Candidate.